• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双侧沃辛瘤——中文文献综述及病例报告

Bilateral Warthin's tumors in a Chinese--literature review and case report.

作者信息

Yang C H, Liu T K, Lu S Y, Eng H L

机构信息

Chang Gung Memorial Hospital, Kaohsiung, Department of Dentistry, Taipei Medical College Hospital, Taiwan, R.O.C.

出版信息

Changgeng Yi Xue Za Zhi. 1990 Dec;13(4):322-35.

PMID:2282569
Abstract

Warthin's tumor is an unusual benign salivary gland tumor. It is predominantly found in Caucasians and is rare in non-Caucasians. The chief affected area of the tumor is the parotid gland. Of all salivary gland neoplasms, Warthin's tumor is the only lesion which is truly multicentric so it may have a second primary lesion, not a recurrence. The peak incidence is in the sixth decade of life. In sexual distribution, there is a male predominance but the incidence of female is progressively increasing. According to Lemelas's study, the increase in female incidence may relate to the increasing population of cigarette smoking of women. Bilateral parotid gland involvement is uncommon. The chief treatment of the tumor is surgical excision. The surgical methods include enucleation, superficial parotidectomy, total parotidectomy. It is very important to protect the facial nerves from injury during surgery. In this paper, we report a case of bilateral metachronous Warthin's tumors with cystic degeneration of parotid glands in a Chinese. Other than literature review and case report, four different methods to protect facial nerves from injury were briefly described.

摘要

沃辛瘤是一种少见的涎腺良性肿瘤。它主要见于白种人,在非白种人中罕见。肿瘤的主要受累部位是腮腺。在所有涎腺肿瘤中,沃辛瘤是唯一真正多中心性的病变,因此它可能有第二个原发灶,而非复发。发病高峰在60岁。在性别分布上,男性居多,但女性发病率在逐渐上升。根据莱梅拉斯的研究,女性发病率的增加可能与女性吸烟人数的增加有关。双侧腮腺受累并不常见。肿瘤的主要治疗方法是手术切除。手术方法包括剜除术、腮腺浅叶切除术、腮腺全切除术。手术中保护面神经免受损伤非常重要。在本文中,我们报告了1例中国人双侧异时性沃辛瘤伴腮腺囊性变的病例。除文献复习和病例报告外,还简要描述了4种保护面神经免受损伤的不同方法。

相似文献

1
Bilateral Warthin's tumors in a Chinese--literature review and case report.双侧沃辛瘤——中文文献综述及病例报告
Changgeng Yi Xue Za Zhi. 1990 Dec;13(4):322-35.
2
Cigarette smoking and Warthin's tumor.吸烟与沃辛瘤
Am J Epidemiol. 1996 Jul 15;144(2):183-7. doi: 10.1093/oxfordjournals.aje.a008906.
3
[Adenolymphoma of the salivary glands. The anatomicoclinical, epidemiological and therapeutic aspects of 76 cases].[涎腺腺淋巴瘤。76例的解剖临床、流行病学及治疗方面]
Minerva Stomatol. 1995 Jul-Aug;44(7-8):325-33.
4
Warthin's tumor (cystadenolymphoma) of salivary glands. A clinicopathologic investigation of 278 cases.涎腺沃辛瘤(腺淋巴瘤)。278例临床病理研究。
Oral Surg Oral Med Oral Pathol. 1986 Mar;61(3):256-62. doi: 10.1016/0030-4220(86)90371-3.
5
Warthin's tumor-associated neoplasms: report of two cases and review of the literature.沃辛瘤相关肿瘤:两例报告并文献复习
Ear Nose Throat J. 1993 Apr;72(4):264-9, 272-3.
6
[Bilateral adenolymphoma (Warthin's tumor) of the parotid. The anatomicoclinical, diagnostic and therapeutic aspects of 2 cases].[腮腺双侧腺淋巴瘤(沃辛瘤)。2例的解剖临床、诊断及治疗方面]
Minerva Stomatol. 1994 Nov;43(11):535-42.
7
Warthin's tumor. Report of a case and survey of 205 salivary neoplasms.沃辛瘤。1例报告及205例涎腺肿瘤的调查。
Oral Surg Oral Med Oral Pathol. 1976 Jan;41(1):129-34. doi: 10.1016/0030-4220(76)90262-0.
8
Warthin's tumor, a multifocal disease.沃辛瘤是一种多灶性疾病。
Ann Otol Rhinol Laryngol. 1982 May-Jun;91(3 Pt 1):246-9. doi: 10.1177/000348948209100303.
9
Role of fine needle aspiration cytology in the diagnosis and management of Warthin's tumour of the salivary glands.细针穿刺细胞学检查在涎腺沃辛瘤诊断和治疗中的作用
Cytopathology. 2010 Jun;21(3):164-9. doi: 10.1111/j.1365-2303.2009.00667.x. Epub 2009 Sep 9.
10
Warthin's tumor. A high incidence and no sex predominance in central Pennsylvania.沃辛瘤。在宾夕法尼亚州中部发病率高且无性别差异。
Arch Otolaryngol Head Neck Surg. 1992 May;118(5):477-8. doi: 10.1001/archotol.1992.01880050023004.